RESEARCH-USE BIOSIMILAR ANTIBODY
Libivirumab
Monoclonal antibody · Not specified
Libivirumab (17.1.41) is a human anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively.
TARGETHepatitis B Virus Surface Antigen
YMonoclonal antibody
CATALOGSC-BS-433
CATALOG NUMBERSC-BS-433
MOLECULAR WEIGHTApprox. 149.04 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Libivirumab (17.1.41) is a human anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively.
Libivirumab is a recombinant research-use antibody directed against Hepatitis B Virus Surface Antigen.